The size of the Empty Capsules Market in the Middle East & Africa is predicted to be worth USD 249.06 million by 2026 from USD 183.42 million in 2021, growing at a CAGR of 6.31% from 2021 to 2026.
On the specified dose form, empty capsules can be stored with herbs, powders, or medicines. The empty capsule can be found in a variety of colors and flavors. Due to their high absorption rates, they are quite popular.
An increase in strategic cooperation between empty capsule providers and gelatin makers and a rise in the appeal of capsules over other drug delivery forms are driving market expansion. In addition, as the world’s senior population grows, the demand for various therapeutic medications and nutritional supplements to improve health outcomes grows.
Furthermore, ongoing research into the manufacture of high-quality empty capsules with the help of government agencies has accelerated the market’s growth rate. In addition, the surge in the popularity of dietary supplements to promote immunity boosts the market’s growth pace. The growing elderly population, the high demand for empty capsules among pharmaceutical, nutraceutical, and cosmeceutical makers, and the growing customer preference for capsules over tablets contribute to the growth of the Middle East Africa empty capsules market.
The growth of the empty capsules market in the MEA region is predicted to be hampered by a dearth of trained workers in laboratories and the government’s strict laws and regulations requiring only high-quality medicines to be approved. In addition, market growth is projected to be hampered by ethical concerns, price variations in gelatin materials, and tight regulations in the pharmaceutical business. Market demand is also hampered by the availability of rival treatments at lower rates and volatility in raw materials costs. Moreover, in this region, a lack of awareness about how to use these items is slowing the growth of the empty capsules market.
This research report on the MEA Empty Capsules Market has been segmented and sub-segmented into the following categories:
By Product:
The gelatin capsules are the most popular product segment, with a major share of the market. Non-gelatin capsules, on the other hand, are expected to grow at the highest rate, with a significant CAGR, due to the rising demand for vegetable origin capsules.
By Therapeutic Application:
By End User:
The pharmaceutical industry is the largest end consumer of empty gelatin capsules, accounting for a significant portion of the market, which is expected to remain stable over the forecast period.
By Country:
The Middle East accounts for the largest market share within this region, while Africa is estimated to be the fastest-growing region. In the MEA empty capsule market, the Middle East has the biggest market share, while Africa is expected to grow at a higher rate. Most nutraceuticals and cosmeceuticals, such as cod liver oil capsules and CosmoPod capsules, are taken in capsule form. The advantages above of capsule consumption account for the high demand for empty capsules in the various industries throughout the region.
The existence of several capsule producers in the UAE and Nigeria, as well as expansion in the pharmaceutical and nutraceutical industries, and less rigorous rules in the nutraceutical industry in this region, are all factors to consider, a growing focus on generics, and rising healthcare awareness, are expected to drive capsule adoption in the MEA. In addition, antibiotic usage has improved dramatically in recent years. Antibiotics are being used indefinitely to treat diseases across the MEA due to rising antibiotic usage, whether prescribed or over the counter.
KEY MARKET PLAYERS:
Capsugel, ACG Worldwide, Suheung Co Ltd., Bright Pharmacaps Inc., Capscanada Corporation, Medi-Caps Ltd., Qualicaps, Roxlor, LLC, Snail Pharma Industry Co.Ltd. And Sunil Healthcare Limited are playing a dominant role in the MEA Empty Capsules Market.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 Gelatin Capsules
5.1.2 Non Gelatin Capsules
5.2 By Therapeutic Applcation
5.2.1 Antibiotic and Antibacterial Drugs
5.2.2 Vitamins and Dietary Supplements
5.2.3 Antacid and Antiflatulent Preparations
5.2.4 Antianemic Preparations
5.2.5 Anti-Inflammatory Drugs
5.2.6 Cardiovascular Therapy Drugs
5.2.7 Cough and Cold Preparations
5.2.8 Other therapeutic applications
5.3 By End User
5.3.1 Pharmaceutical Industry
5.3.2 Nutraceutical Industry
5.3.3 Cosmetics Industry
5.3.4 Research Laboratories
6. Geographical Analysis
6.1 Introduction
6.2 Middle-East
6.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Capsugel
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Suheung Co Ltd.
8.3 Acg Worldwide
8.4 Bright Pharmacaps Inc.
8.5 Capscanada Corporation
8.6 Medi-Caps Ltd.
8.7 Qualicaps
8.8 Roxlor, LLC
8.9 Snail Pharma Industry Co., Ltd.
8.10 Sunil Healthcare Limited
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
